Effect of Yijinjing group training on cognitive function in elderly stroke patients

注册号:

Registration number:

ITMCTR1900002667

最近更新日期:

Date of Last Refreshed on:

2019-10-13

注册时间:

Date of Registration:

2019-10-13

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

定式易筋经团体训练模式对老年脑卒中患者认知状况影响的观察

Public title:

Effect of Yijinjing group training on cognitive function in elderly stroke patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

改良易筋经对老年脑卒中患者认知功能和步行能力的疗效观察

Scientific title:

Effect of modified Yijinjing on cognitive function and walking ability in elderly stroke patients

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900026532 ; ChiMCTR1900002667

申请注册联系人:

薛炘

研究负责人:

胡军

Applicant:

Xue Xin

Study leader:

Hu Jun

申请注册联系人电话:

Applicant telephone:

+86 15202151580

研究负责人电话:

Study leader's telephone:

+86 18918796779

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

750657801@qq.com

研究负责人电子邮件:

Study leader's E-mail:

jasonhwu@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区华佗路280弄22幢27号

研究负责人通讯地址:

上海市浦东新区蔡伦路1200号

Applicant address:

27 Building 22, 280th Lane, Huatuo Road, Pudong New Area, Shanghai, China

Study leader's address:

1200 Cailun Road, Pudong New Area, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学

Applicant's institution:

Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2019-026

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属岳阳中西医结合医院伦理委员会

Name of the ethic committee:

Ethics Committee of Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/3/21 0:00:00

伦理委员会联系人:

殷从全

Contact Name of the ethic committee:

Yin Congquan

伦理委员会联系地址:

上海市虹口区甘河路110号

Contact Address of the ethic committee:

110 Ganhe Road, Hongkou District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学

Primary sponsor:

Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市浦东新区蔡伦路1200号

Primary sponsor's address:

1200 Cailun Road, Pudong New Area, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学

具体地址:

浦东新区蔡伦路1200号

Institution
hospital:

Shanghai University of Traditional of Chinese Medicine

Address:

1200 Cailun Road, Pudong New Area

经费或物资来源:

上海中医药大学预算内项目

Source(s) of funding:

Budget project of Shanghai university of traditional Chinese medicine

研究疾病:

脑卒中

研究疾病代码:

Target disease:

Stroke

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

1. 评价改良易筋经在老年脑卒中患者认知功能和步行能力中的作用; 2. 探索传统功法应用于脑卒中患者康复中的特点。

Objectives of Study:

1. To evaluate the effect of modified Yijinjing on cognitive function and walking ability in elderly stroke patients; 2. To explore the clinical characteristics of traditional Chinese rehabilitation in elderly stroke patients.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1. 符合脑卒中的西医诊断标准或中医诊断标准; 2. 年龄60-75岁,性别不限; 3. 轻度认知障碍:MOCA< 26分(如受教育年限小于等于12年需在检査结果上加1分); 4. 平衡功能:Berg评分21-40分; 5. 患者本人和其法定监护人均同意参加本研究并签署知情同意书。

Inclusion criteria

1. Meet the diagnostic standards of western medicine or traditional Chinese medicine for stroke; 2. Aged 60-75 years, and gender is not limited; 3. Mild cognitive impairment: MOCA< 26 points (if the number of years of education is less than or equal to 12 years, one point should be added to the examination result); 4. Balance function: Berg score 21-40; 5. Both the patient and his legal guardian agree to participate in this study and sign the informed consent.

排除标准:

1. 失语症、听力障碍等无法与他人正常言语沟通患者; 2. 严重骨关节及肌肉疾患; 3. 肝、肾等严重危及生命的疾病及精神病患者; 4. 文化程度低于小学; 5. 目前正在参加其他临床试验者; 6. 目前正在服用改善认知功能的药物者。

Exclusion criteria:

1. Patients with aphasia and hearing impairment who cannot communicate with others in normal speech; 2. Serious bone, joint and muscle diseases; 3. Patients with liver, kidney and other serious life-threatening diseases and mental disorders; 4. Education level than primary school; 5. Currently participating in other clinical trials; 6. Currently taking medications that improve cognitive function.

研究实施时间:

Study execute time:

From 2019-11-01

To      2020-12-31

征募观察对象时间:

Recruiting time:

From 2019-11-01

To      2020-05-01

干预措施:

Interventions:

组别:

易筋经组

样本量:

45

Group:

Yijinjing Group

Sample size:

干预措施:

常规康复治疗和改良易筋经训练

干预措施代码:

Intervention:

Routine rehabilitation and modified Yijinjing training

Intervention code:

组别:

对照组

样本量:

45

Group:

Control Group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

Routine rehabilitation

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海市

市(区县):

上海市

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海金惠康复医院

单位级别:

二级甲等

Institution/hospital:

Shanghai Jinhui Rehabilitation Hospital

Level of the institution:

Secondary A

国家:

中国

省(直辖市):

上海市

市(区县):

上海市

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海中医药大学附属岳阳中西医结合医院

单位级别:

三甲

Institution/hospital:

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

蒙特利尔认知评估量表

指标类型:

主要指标

Outcome:

Montreal cognitive assessment scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

连线测验A

指标类型:

次要指标

Outcome:

TrailMarkingTest-A

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

步态分析测试

指标类型:

主要指标

Outcome:

Gait analysis test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

听觉学习词语测验

指标类型:

次要指标

Outcome:

Chinese auditory verbal learning test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

复杂图形测验

指标类型:

次要指标

Outcome:

Rey complex figure test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数

指标类型:

次要指标

Outcome:

Pittsburgh?sleep?quality?index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 60
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由主要研究者通过SPSS用随机数字表法产生随机数字,进行随机分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The main researcher used SPSS to generate random Numbers and randomly group them.

盲法:

open label

Blinding:

open label

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Resman, http://www.medresman.org

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Resman, http://www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above